Ratio of hemoglobin to red cell distribution width: an inflammatory predictor of survival in AIDS-related DLBCL

BackgroundDespite the introduction of combined antiretroviral therapy, AIDS-related diffuse large B-cell lymphoma (AR-DLBCL) remains a prominent cancer among individuals living with HIV with a suboptimal prognosis. Identifying independent prognostic markers could improve risk stratification.MethodsI...

Full description

Bibliographic Details
Main Authors: Juanjuan Chen, Yihua Wu, Han Zhao, Guangjing Ruan, Shanfang Qin
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1354325/full
_version_ 1827349943040344064
author Juanjuan Chen
Juanjuan Chen
Yihua Wu
Yihua Wu
Han Zhao
Han Zhao
Han Zhao
Guangjing Ruan
Shanfang Qin
author_facet Juanjuan Chen
Juanjuan Chen
Yihua Wu
Yihua Wu
Han Zhao
Han Zhao
Han Zhao
Guangjing Ruan
Shanfang Qin
author_sort Juanjuan Chen
collection DOAJ
description BackgroundDespite the introduction of combined antiretroviral therapy, AIDS-related diffuse large B-cell lymphoma (AR-DLBCL) remains a prominent cancer among individuals living with HIV with a suboptimal prognosis. Identifying independent prognostic markers could improve risk stratification.MethodsIn this multicenter retrospective cohort study spanning years 2011 to 2019, 153 eligible patients with AR-DLBCL were examined. Overall survival (OS) factors were analyzed using Kaplan–Meier curves, and univariate and multivariate Cox proportional hazards models. The discriminatory ability of the risk score was evaluated by examining the area under the receiver operating characteristic curve.ResultsThe study included 153 patients with a median age of 47 years (interquartile range [IQR] 39–58), 83.7% of whom were men. The median follow-up was 12.0 months (95% confidence interval [CI], 8.5–15.5), with an OS rate of 35.9%. Among the potential inflammatory markers examined, only the ratio of hemoglobin (g/dL) to red cell distribution width (%) (Hb/RDW) emerged as an independent prognostic parameter for OS in the training (hazard ratios [HR] = 2.645, 95% CI = 1.267–5.522, P = 0.010) and validation cohorts (HR = 2.645, 95% CI = 1.267–5.522, P = 0.010). A lower Hb/RDW ratio was strongly correlated with adverse clinical factors, including advanced Ann Arbor stage, increased extranodal sites, reduced CD4 count, elevated lactate dehydrogenase levels, poorer Eastern Cooperative Oncology Group performance status (ECOG PS), and a higher International Prognostic Index (IPI) score. The addition of the Hb/RDW ratio to the IPI produced a highly discriminatory prognostic composite score, termed Hb/RDW-IPI.ConclusionWe identified a cost-effective and readily available inflammatory biomarker, the Hb/RDW ratio, as an independent predictor of outcomes in patients with AR-DLBCL. Its integration into the IPI score partially improves prognostic accuracy.
first_indexed 2024-03-08T00:50:42Z
format Article
id doaj.art-267488980ece4dda9af1b377acf83091
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-08T00:50:42Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-267488980ece4dda9af1b377acf830912024-02-15T04:32:08ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-02-011510.3389/fimmu.2024.13543251354325Ratio of hemoglobin to red cell distribution width: an inflammatory predictor of survival in AIDS-related DLBCLJuanjuan Chen0Juanjuan Chen1Yihua Wu2Yihua Wu3Han Zhao4Han Zhao5Han Zhao6Guangjing Ruan7Shanfang Qin8Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaState Key Laboratory of Organ Failure Research, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Guangdong Provincial Clinical Research Center for Viral Hepatitis, Guangdong Institute of Hepatology, Guangzhou, ChinaDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaState Key Laboratory of Organ Failure Research, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Guangdong Provincial Clinical Research Center for Viral Hepatitis, Guangdong Institute of Hepatology, Guangzhou, ChinaDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaState Key Laboratory of Organ Failure Research, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Guangdong Provincial Clinical Research Center for Viral Hepatitis, Guangdong Institute of Hepatology, Guangzhou, ChinaInfectious Diseases Center, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, ChinaGuangxi AIDS Clinical Treatment Center, The Fourth People’s Hospital of Nanning, Nanning, ChinaGuangxi AIDS Diagnosis and Treatment Quality Control Center, Chest Hospital of Guangxi Zhuang Autonomous Region, Liuzhou, ChinaBackgroundDespite the introduction of combined antiretroviral therapy, AIDS-related diffuse large B-cell lymphoma (AR-DLBCL) remains a prominent cancer among individuals living with HIV with a suboptimal prognosis. Identifying independent prognostic markers could improve risk stratification.MethodsIn this multicenter retrospective cohort study spanning years 2011 to 2019, 153 eligible patients with AR-DLBCL were examined. Overall survival (OS) factors were analyzed using Kaplan–Meier curves, and univariate and multivariate Cox proportional hazards models. The discriminatory ability of the risk score was evaluated by examining the area under the receiver operating characteristic curve.ResultsThe study included 153 patients with a median age of 47 years (interquartile range [IQR] 39–58), 83.7% of whom were men. The median follow-up was 12.0 months (95% confidence interval [CI], 8.5–15.5), with an OS rate of 35.9%. Among the potential inflammatory markers examined, only the ratio of hemoglobin (g/dL) to red cell distribution width (%) (Hb/RDW) emerged as an independent prognostic parameter for OS in the training (hazard ratios [HR] = 2.645, 95% CI = 1.267–5.522, P = 0.010) and validation cohorts (HR = 2.645, 95% CI = 1.267–5.522, P = 0.010). A lower Hb/RDW ratio was strongly correlated with adverse clinical factors, including advanced Ann Arbor stage, increased extranodal sites, reduced CD4 count, elevated lactate dehydrogenase levels, poorer Eastern Cooperative Oncology Group performance status (ECOG PS), and a higher International Prognostic Index (IPI) score. The addition of the Hb/RDW ratio to the IPI produced a highly discriminatory prognostic composite score, termed Hb/RDW-IPI.ConclusionWe identified a cost-effective and readily available inflammatory biomarker, the Hb/RDW ratio, as an independent predictor of outcomes in patients with AR-DLBCL. Its integration into the IPI score partially improves prognostic accuracy.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1354325/fullHb/RDW ratioaidsdiffuse large B-cell lymphomaprognostic biomarkerinflammatory index
spellingShingle Juanjuan Chen
Juanjuan Chen
Yihua Wu
Yihua Wu
Han Zhao
Han Zhao
Han Zhao
Guangjing Ruan
Shanfang Qin
Ratio of hemoglobin to red cell distribution width: an inflammatory predictor of survival in AIDS-related DLBCL
Frontiers in Immunology
Hb/RDW ratio
aids
diffuse large B-cell lymphoma
prognostic biomarker
inflammatory index
title Ratio of hemoglobin to red cell distribution width: an inflammatory predictor of survival in AIDS-related DLBCL
title_full Ratio of hemoglobin to red cell distribution width: an inflammatory predictor of survival in AIDS-related DLBCL
title_fullStr Ratio of hemoglobin to red cell distribution width: an inflammatory predictor of survival in AIDS-related DLBCL
title_full_unstemmed Ratio of hemoglobin to red cell distribution width: an inflammatory predictor of survival in AIDS-related DLBCL
title_short Ratio of hemoglobin to red cell distribution width: an inflammatory predictor of survival in AIDS-related DLBCL
title_sort ratio of hemoglobin to red cell distribution width an inflammatory predictor of survival in aids related dlbcl
topic Hb/RDW ratio
aids
diffuse large B-cell lymphoma
prognostic biomarker
inflammatory index
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1354325/full
work_keys_str_mv AT juanjuanchen ratioofhemoglobintoredcelldistributionwidthaninflammatorypredictorofsurvivalinaidsrelateddlbcl
AT juanjuanchen ratioofhemoglobintoredcelldistributionwidthaninflammatorypredictorofsurvivalinaidsrelateddlbcl
AT yihuawu ratioofhemoglobintoredcelldistributionwidthaninflammatorypredictorofsurvivalinaidsrelateddlbcl
AT yihuawu ratioofhemoglobintoredcelldistributionwidthaninflammatorypredictorofsurvivalinaidsrelateddlbcl
AT hanzhao ratioofhemoglobintoredcelldistributionwidthaninflammatorypredictorofsurvivalinaidsrelateddlbcl
AT hanzhao ratioofhemoglobintoredcelldistributionwidthaninflammatorypredictorofsurvivalinaidsrelateddlbcl
AT hanzhao ratioofhemoglobintoredcelldistributionwidthaninflammatorypredictorofsurvivalinaidsrelateddlbcl
AT guangjingruan ratioofhemoglobintoredcelldistributionwidthaninflammatorypredictorofsurvivalinaidsrelateddlbcl
AT shanfangqin ratioofhemoglobintoredcelldistributionwidthaninflammatorypredictorofsurvivalinaidsrelateddlbcl